Toddlers with a peanut allergy built tolerance with 3 years of epicutaneous immunotherapy after a year of placebo use, ...

Among nearly 1,000 youths prescribed montelukast for the first time in a single health system, a history of psychiatric conditions was seen in 22% of those who subsequently received medical care for ...

Researchers have documented the first fatality due to alpha-gal syndrome after consumption of mammalian meat, according to ...

New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut ...

More than 70% of children treated with the Viaskin Peanut Patch could tolerate at least three to four peanut kernels without a reaction after three years, researchers are scheduled to report Saturday ...

Treatment with an experimental peanut protein patch can help young children safely build tolerance to peanuts, University of Colorado researchers reported.

Ongoing peanut patch treatment helps toddlers develop lasting tolerance while remaining safe, offering hope for families managing peanut allergies.

THURSDAY, Nov. 6, 2025 (HealthDay News) — Treatment with an experimental peanut protein patch can help young children safely build tolerance to peanuts, a new study says. More than 70% of children ...

Our brain's reward system processes and reinforces pleasurable experiences, motivating us to seek out and engage in rewarding ...

With a little planning, people can enjoy the celebrations without spending them sniffing, itchy or reaching for tissues.